Risk of second primary malignancy after non-small cell lung cancer: a competing risk nomogram based on the SEER database
Authors:
- 1 September 2019
- journal article
- research article
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (18) , 439
Abstract
Background: With the improvement of survival for non-small cell lung cancer (NSCLC), research focused on second primary malignancy (SPM) in NSCLC survivors is becoming urgent. This study aimed to estimate the risk of SPM in NSCLC patients. Methods: We retrospectively analysed NSCLC patients diagnosed between 2004 and 2010 in SEER database. We firstly evaluated the crude and cumulative incidence of SPM. SPM incidence in NSCLC survivors compared to that in the reference population was calculated as standardized incidence ratio (SIR). A competing risk nomogram was also built, to predict the incidence of SPM. Results: The crude and 10-year cumulative incidences of SPM were 4.04% and 5.05%, respectively, while the SIR was 1.62. The nomogram was well calibrated and had good discriminative ability, with c-index of 0.80. It showed a significantly wide interval of SPM cumulative incidence between the first and tenth-decile according to the risk model (1.04% vs. 16.70%, PConclusions: Our study firstly performed a systematic estimation of the incidence of SPM in NSCLC, which implied the necessity of a risk predicting model. We developed the first competing risk nomogram to predict the risk of SPM, which performed well in the evaluation and might be helpful for individualized SPM screening.Keywords
This publication has 25 references indexed in Scilit:
- Marital Status and Survival in Patients With CancerJournal of Clinical Oncology, 2013
- Family history of cancer and the risk of cancer: a network of case–control studiesAnnals of Oncology, 2013
- Model selection in competing risks regressionStatistics in Medicine, 2013
- Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based study under the Danish Breast Cancer Cooperative Group (DBCG)Radiotherapy and Oncology, 2013
- Nomogram Predicting Long-Term Survival After D2 Gastrectomy for Gastric CancerJournal of Clinical Oncology, 2012
- Das zweite Primärmalignom beim Krebspatienten - Epidemiologie, Prognose und klinische RelevanzZentralblatt fur Chirurgie, 2012
- Competing risks in epidemiology: possibilities and pitfallsInternational Journal of Epidemiology, 2012
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006
- Second Primary Cancers in Patients with Stage III Non-Small Cell Lung Cancer Successfully Treated with Chemo-radiotherapyJapanese Journal of Clinical Oncology, 2005
- Tobacco smoking and cancer: a brief review of recent epidemiological evidenceLung Cancer, 2004